These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1265176)

  • 1. Behavioral depression in Sidman avoidance learning induced by dopamine beta-hydroxylase inhibitors.
    Tamaki Y; Hidaka H
    Psychol Rep; 1976 Apr; 38(2):437-8. PubMed ID: 1265176
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of peripheral dopamine beta-hydroxylase inhibitor to affect discriminated Sidman avoidance learning in rats under long-term training.
    Tamaki Y
    Psychol Rep; 1977 Jun; 40(3 Pt 2):936-8. PubMed ID: 866531
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor.
    Ishii Y; Natsugoe K; Umezawa H
    Arzneimittelforschung; 1975 Feb; 25(2):213-5. PubMed ID: 1173034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of dopamine-beta-hydroxylase inhibitors on avoidance reaction in rat.
    Mogilnicka E; Przewlocka B
    Pol J Pharmacol Pharm; 1975; 27(5):513-9. PubMed ID: 241979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
    Vetulani J; Reichenberg K; wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1973; 25(6):559-72. PubMed ID: 4792476
    [No Abstract]   [Full Text] [Related]  

  • 6. Central dopamine function in affective illness: evidence from precursors, enzyme inhibitors, and studies of central dopamine turnover.
    Goodwin FK; Sack RL
    Adv Biochem Psychopharmacol; 1974; 12(0):261-79. PubMed ID: 4608958
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: In vivo inhibition of dopamine beta-hydroxylase and blood pressure.
    Hidaka H; Hara F; Harada N; Asano M
    Jpn J Pharmacol; 1974; 24(0):s:25. PubMed ID: 4545737
    [No Abstract]   [Full Text] [Related]  

  • 8. The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase.
    Vetulani J
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):501-6. PubMed ID: 4730817
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of delta-1-tetrahydrocannabinol on Sidman discriminated avoidance behavior in rats.
    Willinsky MD; Webster CD; Herring BS
    Act Nerv Super (Praha); 1974 Mar; 16(1):34-8. PubMed ID: 4454932
    [No Abstract]   [Full Text] [Related]  

  • 10. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropharmacological actions of labetalol.
    Dadhich AP; Khanna NK; Vyas DS; Jain P
    Indian J Physiol Pharmacol; 1979; 23(1):39-43. PubMed ID: 437873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inhibition of dopamine-beta-hydroxylase in the peripheral tissues by 5-dimethyldithiocarbamylpicolinic acid; its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure.
    Hidaka H; Hara F; Harada N; Hashizume Y; Yano M
    J Pharmacol Exp Ther; 1974 Dec; 191(3):384-92. PubMed ID: 4473535
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proceedings: Effect of a dopamine-beta-hydroxylase inhibitor (fusaric acid) on thyroid hormones and TSH].
    Yoshimura M; Yatani T; Ochi Y; Nagasaka A; Takeda A
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):88. PubMed ID: 4476662
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibitors of catecholamine biosynthesis (review of the literature)].
    Frantsuzova SB
    Farmakol Toksikol; 1973; 36(5):624-8. PubMed ID: 4150865
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Fusaric acid derivatives: the effect on dopamine beta-hydroxylase.
    Umezawa H; Takeuchi T; Miyano K; Koshigoe K; Hamano H
    J Antibiot (Tokyo); 1973 Mar; 26(3):189. PubMed ID: 4205877
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 18. [Substituted picolinic acids as DBH inhibitors. Inhibition of dopamine beta-hydroxylase and antihypertensive action].
    Piesche L; Hilse H; Oehlke J; Schrötter E; Oehme P
    Pharmazie; 1983 May; 38(5):335-8. PubMed ID: 6611632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.
    Korduba CA; Veals J; Symchowicz S
    J Pharmacol Exp Ther; 1974 Sep; 190(3):459-65. PubMed ID: 4413186
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventive effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on the gastric ulceration induced by water-immersion stress in rats.
    Osumi Y; Takaori S; Fujiwara M
    Jpn J Pharmacol; 1973 Dec; 23(6):904-6. PubMed ID: 4544702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.